It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Lysine-specific histone demethylase 1 (LSD1) is a histone demethylase that plays a critical role in epigenetic regulation by removing the methyl group from mono- and di-methylated lysine 4 on histone H3 (H3K4me1/2), acting as a repressor of gene expression. Recently, catalytically independent functions of LSD1, serving as a scaffold for assembling chromatin-regulator and transcription factor complexes, have been identified. Herein, we show for the first time that LSD1 interacts with chromodomain-helicase-DNA-binding protein 7 (CHD7) in mouse embryonic stem cells (ESCs). To further investigate the CHD7–LSD1 crosstalk, we engineered Chd7 and Chd7/Lsd1 knockout (KO) mouse ESCs. We show that CHD7 is dispensable for ESC self-renewal and survival, while Chd7 KO ESCs can differentiate towards embryoid bodies (EBs) with defective expression of ectodermal markers. Intriguingly, Chd7/Lsd1 double KO mouse ESCs exhibit proliferation defects similar to Lsd1 KO ESCs and have lost the capacity to differentiate properly. Furthermore, the increased co-occupancy of H3K4me1 and CHD7 on chromatin following Lsd1 deletion suggests that LSD1 is required for facilitating the proper binding of CHD7 to chromatin and regulating differentiation. Collectively, our results suggest that LSD1 and CHD7 work in concert to modulate gene expression and influence proper cell fate determination.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Umeå University, Department of Molecular Biology, Umeå, Sweden (GRID:grid.12650.30) (ISNI:0000 0001 1034 3451); Umeå University, Wallenberg Centre for Molecular Medicine, Umeå, Sweden (GRID:grid.12650.30) (ISNI:0000 0001 1034 3451)
2 Karolinska Institutet, Science for Life Laboratory, Department of Oncology-Pathology, Solna, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
3 Universidade de Santiago de Compostela (USC)-Health Research Institute (IDIS), Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Santiago de Compostela, Spain (GRID:grid.11794.3a) (ISNI:0000000109410645)
4 University of Extremadura, Department of Biochemistry, Molecular Biology and Genetics, Badajoz, Spain (GRID:grid.8393.1) (ISNI:0000 0001 1941 2521)